Neuroscience & cognitive health
Neuropsychiatric disorders are one of the most important causes of global disability and lost productivity. Work from Oxford Clinical Trials is driving science-based treatment advance in this area.
Translational neuroscience pulls through advances in basic neuroscience into better treatments for patients. Trials in this area can be difficult to conduct but trialists at the University of Oxford harness their considerable expertise in clinical trials with an understanding of the clinical needs of patients to deliver successful results
At a glance
| Groups: | Oxford Cognitive Health and Neuroscience Clinical Trials Unit | |
|---|---|---|
| Specialisms: | Cognitive health, mental health and clinical neurosciences | |
| Phases: | I, II, III, IV | |
| Current trials: | CEQUEL, OCTUMI-4, OXTEXT 6, MIAMI, OPT, WIT, OCTET, Redkite, Aripiprazole for hyperprolactinaemia , OxIGen, Oxford Cognitive Health Exercise Trial |